» Articles » PMID: 28162769

Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2017 Feb 7
PMID 28162769
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess whether cord blood biomarkers associated with placental maternal vascular underperfusion (MVU) are predictive of bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH).

Study Design: Premature infants enrolled in a longitudinal cohort study were randomly sampled from 4 gestational age strata (n?=?190, range 23-36 weeks). Fifteen factors from a human angiogenesis panel were measured in cord blood using multiplex immunoassay. Multivariate linear regression was used to compare biomarker levels according to placental histologic MVU, taking into account acute/chronic inflammation and fetal vascular pathology. Biomarkers associated with MVU were further evaluated in the subgroup of extremely low gestational age infants (gestational age ? 28 weeks; n?=?48), and measured by enzyme-linked immunoassay in an additional 39 infants to determine associations with BPD (defined using the National Institutes of Health workshop criteria) and PH (identified by echocardiogram at 36 weeks of gestation).

Results: Cord blood placental growth factor (PIGF), granulocyte-colony stimulating factor (G-CSF), and vascular endothelial growth factor-A were decreased with MVU (P?<?.003), and decreased with BPD-PH (P?<?.05). The findings were validated for PIGF and G-CSF in 39 additional extremely low gestational age infants. In the combined group (n?=?87), PIGF was decreased in infants with BPD-PH (n?=?21) versus controls without PH (median 3 pg/mL [IQR 2-7] vs median 15 pg/mL [IQR 6-30], respectively; P?<?.001). G-CSF was similarly decreased with BPD-PH (median, 55 pg/mL [IQR 38-85] vs median 243 pg/mL [IQR 48-1593], respectively; P?=?.001). Receiver operator curve analysis revealed that decreased PIGF and G-CSF were predictive of BPD-PH (area under the curve 0.83 and 0.76, respectively).

Conclusions: Cord blood angiogenic factors that are decreased with placental MVU may serve as predictors of BPD-PH.

Citing Articles

Impact of placental pathology on the risk of bronchopulmonary dysplasia in preterm infants: The role of gestational age and sex.

Ramos-Navarro C, Gregorio-Hernandez R, Perez-Perez A, Rodriguez-Corrales E, Vigil-Vazquez S, Arriaga-Redondo M Eur J Pediatr. 2025; 184(3):211.

PMID: 40009187 DOI: 10.1007/s00431-025-06016-9.


Nintedanib as a strategy to prevent bronchopulmonary dysplasia: dosing and tim(-ing) is of the essence.

Mathias M, Ganguly A, Tipple T Pediatr Res. 2024; .

PMID: 39528746 DOI: 10.1038/s41390-024-03713-3.


Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension.

Pharande P, Sehgal A, Menahem S J Cardiovasc Dev Dis. 2024; 11(8).

PMID: 39195141 PMC: 11354795. DOI: 10.3390/jcdd11080233.


Cord Blood Adductomics Reveals Oxidative Stress Exposure Pathways of Bronchopulmonary Dysplasia.

Lin E, Bae Y, Birkett R, Sharma A, Zhang R, Fisch K Antioxidants (Basel). 2024; 13(4).

PMID: 38671941 PMC: 11047351. DOI: 10.3390/antiox13040494.


Macrophage Polarizations in the Placenta and Lung are Associated with Bronchopulmonary Dysplasia.

Mestan K, Sharma A, Lazar S, Pandey S, Parast M, Laurent L bioRxiv. 2024; .

PMID: 38352616 PMC: 10862768. DOI: 10.1101/2024.01.26.577443.


References
1.
Ehrenkranz R, Walsh M, Vohr B, Jobe A, Wright L, Fanaroff A . Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005; 116(6):1353-60. DOI: 10.1542/peds.2005-0249. View

2.
Bhat R, Salas A, Foster C, Carlo W, Ambalavanan N . Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012; 129(3):e682-9. PMC: 3289526. DOI: 10.1542/peds.2011-1827. View

3.
Marwa B, Raguema N, Zitouni H, Feten H, Olfa K, Elfeleh R . FGF1 and FGF2 mutations in preeclampsia and related features. Placenta. 2016; 43:81-5. DOI: 10.1016/j.placenta.2016.05.007. View

4.
Furmento V, Marino J, Blank V, Roguin L . The granulocyte colony-stimulating factor (G-CSF) upregulates metalloproteinase-2 and VEGF through PI3K/Akt and Erk1/2 activation in human trophoblast Swan 71 cells. Placenta. 2014; 35(11):937-46. DOI: 10.1016/j.placenta.2014.09.003. View

5.
Nakanishi H, Uchiyama A, Kusuda S . Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J Perinatol. 2016; 36(10):890-6. PMC: 5050265. DOI: 10.1038/jp.2016.108. View